Gilead Sciences has announced that it will charge $3,120 for a five-day treatment course with its antiviral drug remdesivir. Outside of the United States, the drug company said it would charge $2,340 for the five-day course with remdesivir. Hospitals and insurers will now be charged for remdesivir.
The FDA approved Fintepla (fenfluramine), developed by Zogenix, for the treatment of convulsive seizures associated with Dravet syndrome, an early childhood-onset epileptic condition. Fintepla has been approved for children above 2 years. The drug is expected to be available by the end of July.
At Worldwide Developers Conference (WWDC), Apple executives announced new developments that are expected this fall. Among the new developments are the hand-washing alerts on your Apple Watch that will nudge you to wash your hands regularly in order to prevent the spread of the coronavirus.
A recent study has found that headache is one of the key symptoms of COVID-19, which persisted even after other symptoms resolved. This suggests the clinical evolution of COVID-19, helping clinicians to better understand migraine and other types of headaches.
According to a new survey, conducted during COVID pandemic, there has been a threefold increase in the percentage of Americans reporting the symptoms of psychological distress from 2018 to April 2020. Social distancing, fear of catching the infection, unemployment, and economic crisis have negatively affected psychological health.
Netakimab, a humanized monoclonal antibody that targets interleukin-17A, has been found effective at treating moderate to severe skin manifestations caused by psoriasis. In a clinical trial, the drug has significantly improved the skin manifestations of psoriasis.
As the number of coronavirus cases continues to grow, there has been a sharp rise in racist attacks and violent fights targeting Asian Americans. Asian American doctors are nurses are facing verbal attacks from frustrated patients, blaming them for the spread of the virus.